microdosing glp-1 benefits for Preventative Health The Hidden Benefits of Microdosing

Some have plausible mechanisms and early evidence

H., et al., Development of Novel NLRP3XOD Dual Inhibitors for the Treatment of Gout, Bioorganic & Medicinal Chemistry Letters 30 (2020): 126944, 10.1016/j.bmcl.2019.126944

A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1